Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

EDIT, HTGM, NTNX, TWTR

Published 03/08/2018, 01:06 AM
Updated 07/09/2023, 06:31 AM

Editas Medicine Inc (NASDAQ:EDIT) broke out on Wednesday, jumping 3.84, or 10%, to 42.28, on 4.4 million shares traded. The all-time high is at 43.99, and Wednesday’s high was 43.25, so it's very close to the all-time high. It looks to me like it wants to extend up near 50. My target is 49-50.

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) popped on Wednesday, gaining 71 cents, or 16%, to 5.10, on 3.2 million shares traded. The volume picked up. The OBV , Balance of Power and Money Stream all did great for this stock on Wednesday. I’m looking for more upside. Targets are 6 3/4-7, and then 8 1/2-9.

Nutanix Inc (NASDAQ:NTNX) has been a swing trade of ours since Aug when it was trading in the 20-20 1/2 range and moved up nicely. It was up another 1.52, or 3.44%, to 45.65, on 7.5 million shares traded on Wednesday. It went to 46 right at resistance. Next target is up around 52-3.

Twitter Inc (NYSE:TWTR) is extending. It was up another 1.33, or 3.86%, to 35.76, on 34 million shares traded on Wednesday. That’s big volume. It looks like it’s headed to 38, and then 42.

On the long side stocks included Abercrombie & Fitch Co. (ANF), Cerecor Inc. (CERC), Clearside BioMedical, Inc. (CLSD), CRISPR Therapeutics AG (CRSP), Editas Medicine Inc. (EDIT), Everbridge, Inc. (EVBG), HTG Molecular Diagnostics, Inc. (HTGM), Direxion Daily S&P Biotech Bull 3X ETF (LABU), MediciNova, Inc. (MNOV), Momo Inc. (MOMO), MuleSoft, Inc. (MULE), Mazor Robotics Ltd. (MZOR), Nektar Therapeutics (NKTR), NUTANIX, INC. (NTNX), ShiftPixy, Inc. Common Stock (PIXY), PTC Therapeutics, Inc. (PTCT), Splunk, Inc. (SPLK), Square, Inc. (NYSE:SQ), Sarepta Therapeutics, Inc. (SRPT), Twitter, Inc. (TWTR), Vericel Corporation (VCEL), Zosano Pharma Corporation (ZSAN).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.